111 related articles for article (PubMed ID: 21917987)
1. Native α6β4* nicotinic receptors control exocytosis in human chromaffin cells of the adrenal gland.
Pérez-Alvarez A; Hernández-Vivanco A; McIntosh JM; Albillos A
FASEB J; 2012 Jan; 26(1):346-54. PubMed ID: 21917987
[TBL] [Abstract][Full Text] [Related]
2. Ribbon α-Conotoxin KTM Exhibits Potent Inhibition of Nicotinic Acetylcholine Receptors.
Marquart LA; Turner MW; Warner LR; King MD; Groome JR; McDougal OM
Mar Drugs; 2019 Nov; 17(12):. PubMed ID: 31795126
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic concentrations of varenicline increases exocytotic release of catecholamines from human and rat adrenal chromaffin cells in the presence of nicotine.
Jiménez-Pompa A; Sanz-Lázaro S; Hone AJ; Rueda-Ruzafa L; Medina-Polo J; González-Enguita C; Blázquez J; de Los Ríos C; Michael McIntosh J; Albillos A
Neuropharmacology; 2021 Sep; 195():108632. PubMed ID: 34097947
[TBL] [Abstract][Full Text] [Related]
4. Computational and Functional Mapping of Human and Rat α6β4 Nicotinic Acetylcholine Receptors Reveals Species-Specific Ligand-Binding Motifs.
Hone AJ; Kaas Q; Kearns I; Hararah F; Gajewiak J; Christensen S; Craik DJ; McIntosh JM
J Med Chem; 2021 Feb; 64(3):1685-1700. PubMed ID: 33523678
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Activity, and Application of Fluorescent Analogs of [D1G, Δ14Q]LvIC Targeting α6β4 Nicotinic Acetylcholine Receptor.
Pei S; Xu C; Tan Y; Wang M; Yu J; Zhangsun D; Zhu X; Luo S
Bioconjug Chem; 2023 Dec; 34(12):2194-2204. PubMed ID: 37748043
[TBL] [Abstract][Full Text] [Related]
6. Nicotinic Receptors in Human Chromaffin Cells: Characterization, Functional and Physical Interactions between Subtypes and Regulation.
Jiménez-Pompa A; Albillos A
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396980
[TBL] [Abstract][Full Text] [Related]
7. A Novel α4/7-Conotoxin QuIA Selectively Inhibits α3β2 and α6/α3β4 Nicotinic Acetylcholine Receptor Subtypes with High Efficacy.
Wang L; Wu X; Zhu X; Zhangsun D; Wu Y; Luo S
Mar Drugs; 2022 Feb; 20(2):. PubMed ID: 35200675
[TBL] [Abstract][Full Text] [Related]
8. Cross Talk between α7 and α3β4 Nicotinic Receptors Prevents Their Desensitization in Human Chromaffin Cells.
Jiménez-Pompa A; Sanz-Lázaro S; Omodolor RE; Medina-Polo J; González-Enguita C; Blázquez J; McIntosh JM; Albillos A
J Neurosci; 2022 Feb; 42(7):1173-1183. PubMed ID: 34965978
[TBL] [Abstract][Full Text] [Related]
9. A Variant in the Nicotinic Acetylcholine Receptor Alpha 3 Subunit Gene Is Associated With Hypertension Risks in Hypogonadic Patients.
Wu T; Wang Y; Shi W; Zhang BQ; Raelson J; Yao YM; Wu HD; Xu ZX; Marois-Blanchet FC; Ledoux J; Blunck R; Sheng JZ; Hu SJ; Luo H; Wu J
Front Genet; 2020; 11():539862. PubMed ID: 33329690
[No Abstract] [Full Text] [Related]
10. α-Conotoxin VnIB from Conus ventricosus is a potent and selective antagonist of α6β4* nicotinic acetylcholine receptors.
van Hout M; Valdes A; Christensen SB; Tran PT; Watkins M; Gajewiak J; Jensen AA; Olivera BM; McIntosh JM
Neuropharmacology; 2019 Oct; 157():107691. PubMed ID: 31255696
[TBL] [Abstract][Full Text] [Related]
11. Nerve Stimulation: Immunomodulation and Control of Inflammation.
Ulloa L; Quiroz-Gonzalez S; Torres-Rosas R
Trends Mol Med; 2017 Dec; 23(12):1103-1120. PubMed ID: 29162418
[TBL] [Abstract][Full Text] [Related]
12. Human nicotinic receptors in chromaffin cells: characterization and pharmacology.
Albillos A; McIntosh JM
Pflugers Arch; 2018 Jan; 470(1):21-27. PubMed ID: 29058146
[TBL] [Abstract][Full Text] [Related]
13. TC299423, a Novel Agonist for Nicotinic Acetylcholine Receptors.
Wall TR; Henderson BJ; Voren G; Wageman CR; Deshpande P; Cohen BN; Grady SR; Marks MJ; Yohannes D; Kenny PJ; Bencherif M; Lester HA
Front Pharmacol; 2017; 8():641. PubMed ID: 29033834
[TBL] [Abstract][Full Text] [Related]
14. Insights Into Nicotinic Receptor Signaling in Nicotine Addiction: Implications for Prevention and Treatment.
Liu W; Li MD
Curr Neuropharmacol; 2018; 16(4):350-370. PubMed ID: 28762314
[TBL] [Abstract][Full Text] [Related]
15. α-Conotoxins Identify the α3β4* Subtype as the Predominant Nicotinic Acetylcholine Receptor Expressed in Human Adrenal Chromaffin Cells.
Hone AJ; McIntosh JM; Azam L; Lindstrom J; Lucero L; Whiteaker P; Passas J; Blázquez J; Albillos A
Mol Pharmacol; 2015 Nov; 88(5):881-93. PubMed ID: 26330550
[TBL] [Abstract][Full Text] [Related]
16. Natural compounds interacting with nicotinic acetylcholine receptors: from low-molecular weight ones to peptides and proteins.
Kudryavtsev D; Shelukhina I; Vulfius C; Makarieva T; Stonik V; Zhmak M; Ivanov I; Kasheverov I; Utkin Y; Tsetlin V
Toxins (Basel); 2015 May; 7(5):1683-701. PubMed ID: 26008231
[TBL] [Abstract][Full Text] [Related]
17. Nicotinic receptor Alpha7 expression during mouse adrenal gland development.
Gahring LC; Myers E; Palumbos S; Rogers SW
PLoS One; 2014; 9(8):e103861. PubMed ID: 25093893
[TBL] [Abstract][Full Text] [Related]
18. Roles for N-terminal extracellular domains of nicotinic acetylcholine receptor (nAChR) β3 subunits in enhanced functional expression of mouse α6β2β3- and α6β4β3-nAChRs.
Dash B; Li MD; Lukas RJ
J Biol Chem; 2014 Oct; 289(41):28338-51. PubMed ID: 25028511
[TBL] [Abstract][Full Text] [Related]
19. Diverse strategies targeting α7 homomeric and α6β2* heteromeric nicotinic acetylcholine receptors for smoking cessation.
Brunzell DH; McIntosh JM; Papke RL
Ann N Y Acad Sci; 2014 Oct; 1327(1):27-45. PubMed ID: 24730978
[TBL] [Abstract][Full Text] [Related]
20. Monkey adrenal chromaffin cells express α6β4* nicotinic acetylcholine receptors.
Hernández-Vivanco A; Hone AJ; Scadden ML; Carmona-Hidalgo B; McIntosh JM; Albillos A
PLoS One; 2014; 9(4):e94142. PubMed ID: 24727685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
